Shareholder Structure
At the beginning of 2008, we again conducted a survey of our shareholder structure. The total number of outstanding ordinary shares was 296,564,670. With 36% or about 107 million ordinary shares, the holdings of Fresenius SE remained nearly unchanged compared to the previous year. In total we identified just under 400 investors. Based on the free float 189,961,076, i.e. without the shareholdings of Fresenius SE, we were able to attribute about 71% or 134 million shares to their owners. The fraction of non-identified shares was about 29% or nearly 56 million shares of the free float. The top 25 investors held about 22% of our ordinary shares.
Most of our free-float shares continue to be held in the Great Britain and the Republic of Ireland as well as the U.S.: 34% are held by investors in Great Britain and Ireland, 28% are held by U.S. and Canadian investors. Some 15% of our shareholders are located in Germany. Other European investors hold about 20%, a significant increase compared to 2006 with 14%.
The proportion of shares held in the U.S. and Canada remained nearly constant, all other regions experienced a slight decrease compared to previous year.
Number of identified Shares*
2007 |
Shares | % of total | % of Free Float | |
| Total number of shares | 296,564,670 | ||
| Fresenius SE | 106,603,026 | 36% | |
| Free Float | 189,961,076 | 64% | |
| .Identified Free Float | 134,090,929 | 45% | 71% |
| ...Institutional Investors | 131,169,040 | 44% | 69% |
| ...Private Investors | 2,921,889 | 1% | 2% |
| Non-identified shares | 55,870,147 | 19% | 29% |
2006 |
Shares | % of total | % of Free Float | |
| Total number of shares | 294,994,596 | ||
| Fresenius SE | 106,603,026 | 36% | |
| Free Float | 187,886,766 | 64% | |
| .Identified Free Float | 159,455,049 | 54% | 85% |
| ...Institutional Investors | 151,577,673 | 51% | 81% |
| ...Private Investors | 7,877,376 | 3% | 4% |
| Non-identified shares | 28,431,717 | 10% | 15% |
Regional Distribution of Identified Free Float*
2007 | 2006 |
Shares | % of total | Shares | % of total | |
| Great Britain & Ireland | 44,963,400 | 34% | 57,683,712 | 36% |
| U.S. & Canada | 37,418,971 | 28% | 43,441,134 | 27% |
| Germany | 20,238,719 | 15% | 27,155,802 | 17% |
| Rest of Europe | 27,426,150 | 20% | 23,052,915 | 14% |
| Rest of World | 4,043,698 | 3% | 8,121,486 | 6% |
| TOTAL | 134,090,929 | 100% | 159,455,049 | 100% |
* Data based on shareholder identification of February 2008.
Awards 2008
- Thomson Extel Surveys: IR Excellence Award 2008
- Capital: Investor Relations Award 2008 for the best IR in the DAX
- Institutional Investor: Best European Investor Relations in the Healthcare Sector in 2008
- LACP: Platinum Awards for the Annual Report 2007
- IR Global Rankings: Best IR Team and TOP 1 Online Annual Report in the Industry
Awards 2007
- Thomson Extel Surveys: Best IR Work in Europe 2007
- Institutional Investor: Best European Investor Relations in the Healthcare Sector in 2007
- Capital: Investor Relations Award 2007 for the best IR in the DAX
- Manager Magazin: Best Annual Report 2007 in the DAX
- LACP: Platinum Award for the Annual Report 2006




top